One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.

In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the reach of CAR T-cell therapies into solid tumor indications.

Cell culture plates in the Roeder lab where scientists recently studied gene expression in breast cancer. (Credit: Lori ...

Chromosome compartment analysis of a cancer cell line cohort reveals different subsets of compartment changes where some track epithelial to mesenchymal transition while others reflect secondary ...

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...

Stem cells possess the unique abilities of self-renewal and differentiation into various cell types, making them highly ...

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...